Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Amino 4 Bromopyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for 2,3-diamino-4-bromopyridine offers high yield and cost efficiency for kinase inhibitor manufacturing supply chains and global procurement.
Patent CN101863830A reveals a high-yield synthesis of 2-amino-5-bromoisonicotinic acid (>60%), offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN102603622B reveals a high-yield route for 2-amino-4-bromopyridine, offering significant cost reduction and scalability for pharmaceutical manufacturing.